Funding Partners

The Canadian Cancer Society-Nova Scotia Division (CCNS-NSD) funds research into all cancers through its national Canadian Cancer Society Research Institute. Locally, the CCS-NSD supports the annual CCS Carol Ann Cole Comfort Heart Studentship Award.

Craig's Cause Pancreatic Cancer Society provides information and support to those with pancreatic cancer and their families. They partner with BHCRI to support cancer research trainees undertaking pancreatic cancer research.

The Dalhousie Medical Research Foundation (DMRF) has invested more than $8 million in local cancer research over the years, and works hand in hand with the Dalhousie Faculty of Medicine to provide strategic research support to trainees, investigators, facilities and new initiatives.

This annual studentship fund supports an Atlantic Canadian student working on their summer research project at BHCRI.  Dr. Hoskin is a BHCRI Senior Scientist, has served on the BHCRI Working Group, BHCRI Development Board, CRTP Management Committee and BHCRI Training Committee. Dr. Hoskin has also been a supervisor for CRTP trainees.

GIVETOLIVE has been supporting BHCRI since 2017 through their Big Ride. The Big Ride challenges participants to get out of their comfort zone and cycle a long distance in a short amount of time, all while having fun and raising funds to support cancer research. GIVETOLIVE’s mission is to inspire people to live happy and healthy lives through generosity, fitness, and achievement of the extraordinary.

The IWK Foundation supports cancer research through two special endowment funds that honour the memory and vision of remarkable individuals and families.

The Charlie and Dan MacDougall Cancer Research Endowment Fund was established in honour of Chris and Karen MacDougall’s sons, Charlie and Dan. Chris MacDougall, a former BHCRI Board Chair, created Charlie’s Ride for Cancer Research — cycling across Canada in 2016 and around Iceland in 2017 — to raise awareness and funds for cancer research. The proceeds established the Charlie & Dan MacDougall Fund for Cancer Research through the Dalhousie Medical Research Foundation, with annual income supporting the Beatrice Hunter Cancer Research Institute.

The Jeremy Ingham Cancer Research Trust was created to fulfill Jeremy’s dream of improving outcomes for patients — especially children and young adults — with cancer. Award recipients supported through this trust carry on Jeremy’s legacy and his vision of bringing a cure one step closer.

The J.D. Irving, Limited Excellence in Cancer Research Fund is proud to support the Cancer Research Training Program at BHCRI. In 2021, J.D. Irving, Limited donated $2.5million to the Canadian Cancer Society to establish the Excellence in Cancer Research Fund, affirming the company“s longstanding commitment to invest in research in Atlantic Canada. The Fund will build, strengthen and expand cancer research potential and capacity in the region, and it will ensure the highest-quality, most-promising ideas and people are supported (based on a rigourous peer review process). This enables scientists to develop and continue their critical research in Atlantic Canada and contribute to the larger national cancer research landscape.

The New Brunswick Health Research Foundation (NBHRF) provides leadership and support to build health research capacity, improve the health of New Brunswickers and advance the knowledge economy. BHCRI and NBHRF partner to support New Brunswick-based cancer researchers.

The QEII Foundation facilitated the establishment of two endowed cancer research chairs and continues to actively support cancer research initiatives through BHCRI. The Foundation raises funds for technology, community-based disease prevention initiatives, professional education and medical research.

The Saunders Matthey Fund was started in 1996 by Ray Matthey in memory of his wife and daughter. Funds provide support for trainees and senior investigators focused on cancer research, education and prevention. An emphasis is also placed on how environmental factors may be contributing to cancer.

The Terry Fox Research Institute has been a partner since BHCRI’s establishment in 2009, TFRI’s Atlantic Node provides travel bursaries for trainees attending national cancer meetings and co-sponsors the annual CRTP Cancer Workshop and biennial Conference.

In 2018, the Atlantic Cancer Consortium (ACC) was established as part of the Marathon of Hope Cancer Centres Network (MoHCCN) — a pan-Canadian initiative led by the Terry Fox Foundation and TFRI, with support from partner institutions across Atlantic Canada. Focusing on precision medicine, ACC brings together the region’s leading cancer researchers to improve diagnosis, predict treatment response, and deliver more personalized and effective care for patients.